Vega Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.49 M
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.80 M
- Revenue Growth 21.69%
- Profit Growth 185.52%
- Ebitda 348.42%
- Net Worth 2.02%
- Total Assets 0.55%
About Vega Laboratories
Vega Laboratories Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 1996 and has a history of 28 years and ten months. Its registered office is in New Delhi, Delhi.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹0.80 M.
Trilok Goyal and Rajeev Sehgal serve as directors at the Company.
Company Details
- Location New Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL1996PTC078309
- Company No.
078309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Vega Laboratories Private Limited offer?
Vega Laboratories Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Nutraceuticals & Dietary Supplements, Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Vega Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Trilok Goyal  | Director | 19-Apr-1996 | Current |
| Rajeev Sehgal | Director | 19-Apr-1996 | Current |
Financial Performance of Vega Laboratories.
Vega Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.69% increase. The company also saw a substantial improvement in profitability, with a 185.52% increase in profit. The company's net worth moved up by a moderate rise of 2.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vega Laboratories?
In 2022, Vega Laboratories had a promoter holding of 78.95% and a public holding of 21.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.80 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2003 | Bank Of India | ₹0.80 M | Open |
How Many Employees Work at Vega Laboratories?
Unlock and access historical data on people associated with Vega Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vega Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vega Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
